| 000 | 01329 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513190410.0 | ||
| 264 | 0 | _c19990909 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0887-8994 | ||
| 024 | 7 |
_a10.1016/s0887-8994(99)00022-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLahat, E | |
| 245 | 0 | 0 |
_aAminoaciduria resulting from vigabatrin administration in children with epilepsy. _h[electronic resource] |
| 260 |
_bPediatric neurology _cJul 1999 |
||
| 300 |
_a460-3 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAmino Acids _xurine |
| 650 | 0 | 4 |
_aAminoisobutyric Acids _xurine |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aVigabatrin |
| 650 | 0 | 4 |
_abeta-Alanine _xurine |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xadverse effects |
| 700 | 1 | _aBen-Zeev, B | |
| 700 | 1 | _aZlotnik, J | |
| 700 | 1 | _aSela, B A | |
| 773 | 0 |
_tPediatric neurology _gvol. 21 _gno. 1 _gp. 460-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0887-8994(99)00022-3 _zAvailable from publisher's website |
| 999 |
_c10386359 _d10386359 |
||